CMII - Proteomics May Be The Future Of Biotech Quantum-Si Is A Potential Leader

• Proteomics has the potential to revolutionize medicine in potentially the same way that genomics has. The traditional field looks primed for disruption and that effort could hit critical mass soon.
• Quantum-Si has set forth a business plan to utilize consumables as the primary driver of revenues and achieve a long-term goal of 70% margins.
• Significant revenues for Quantum-Si are still a few years off but next-generation technology is just now going through the final touches before commercialization.
• Quantum-Si looks to potentially be a leader in this burgeoning field, validation may take years to achieve however so this is a highly speculative stock and caution is warranted.

For further details see: